MedDataX Logo

A Training of the Rhythmic Skills With a Serious Game to Improve Gait and Cognitive Abilities in Parkinson's Disease

NCT ID: NCT02855710

Last Updated: 2021-12-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

SUSPENDED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-03-04

Study Completion Date

2022-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims at assessing the opposite relation, namely the effect of a training of the general timing abilities on gait in Parkinson's disease. Timing rehabilitation will be done by the means of a serious game. Serious games are more and more used to improve the compliance and the efficacy of reeducaiton programs. Overall, we propose to test a low-cost tool for rehabilitation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Auditory rythmic cueing is a method consisting in presenting a regular auditory stimulus (metronom or music) when someone is walking. It is known to improve gait in pathologies such as Parkinson's disease. It has also an effect on general timing abilities (e.g. tapping the beat of the music). This project aims at assessing the opposite relation, namely the effect of a training of the general timing abilities on gait in Parkinson's disease. Timing rehabilitation will be done by the means of a serious game. Serious games are more and more used to improve the compliance and the efficacy of reeducaiton programs. Overal, we propose to test a low-cost tool for rehabilitation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

No training

Parkinsonian Patients with no Rhythm Workers training perceptive timing and senrorimotor timing

Group Type OTHER

No Rhythm workers training

Intervention Type OTHER

No training

Perceptive timing training

Parkinsonian Patients with Rhythm Workers training perceptive timing

Group Type OTHER

Rhythm workers training Perceptive timing

Intervention Type OTHER

Perceptive timing training

Sensorimotor timing training

Parkinsonian Patients with Rhythm Workers training sensorimotor timing

Group Type OTHER

Rhythm workers training sensorimotor timing

Intervention Type OTHER

Sensorimotor timing training

Healthy volunteers

Healthy people with Rhythm Workers training perceptive timing

Group Type OTHER

Rhythm workers training Perceptive timing

Intervention Type OTHER

Perceptive timing training

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rhythm workers training Perceptive timing

Perceptive timing training

Intervention Type OTHER

Rhythm workers training sensorimotor timing

Sensorimotor timing training

Intervention Type OTHER

No Rhythm workers training

No training

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \< 18
* good understanding of the nature, the goal and the methodology of the study
* signing of the informed consent
* being insured with a social security
* Diagnostic of idiopathic Parkinson's disease following the Queen Square Brain Bank (Hughes, 1992)
* Hoehn et Yahr between 2 and 3
* mild to moderate walk and speech deficits (Item MDS-UPDRS)
* stable therapy one month before inclusion for all the duration of the study

Exclusion Criteria

* Atypic Parkinson Syndrom (oculomotor troubles, early falls, hallucinations, MoCA\<20, early dysautonomy)
* dystonia ou dyskinesia preventing from using a tablet (item MDS-UPDRS4.2 \>2)
* Unable to move without help (walking stick, walker, wheelchair) (item MDS-UPDRS 2.12 \>2)
* adult protected by law
* deprivation of liberty
* High propability of non compliance to the protocol
* pregnant women, nursing women
* moderate to severe auditory trouble
* Severe walk fluctuations item MDS-UPDRS 4.4 \>2)
* Pacemaker or neurosensorial device or heart defebrillator
* Cochlear implants
* ferromagnetic external bodies claose to the brain
* Metallic prothesis
* agitated, non cooperative patient
* claustrophobic patient
* neuro-surgical shunt valves
* dental appliance
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laboratory Parole et Langage UMR 7309

UNKNOWN

Sponsor Role collaborator

Laboratory EUROMOV EA 2991

UNKNOWN

Sponsor Role collaborator

Université Montpellier

OTHER

Sponsor Role collaborator

University Hospital, Montpellier

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Gény, MD

Role: STUDY_CHAIR

University Hospital, Montpellier

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gui de Chauliac Hospital

Montpellier, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

9499

Identifier Type: -

Identifier Source: org_study_id